Archives for December 6, 2006

← 2006

Nanomechanical devices detect disease

By  Mike Nagle

The dream of personalised medicine has taken another step towards reality as scientists have developed an innovative nanomechanical sensor for detecting disease and observing the body's reaction to treatment.

Viagra faces stiff competition from gene therapy

By  Dr Matt Wilkinson

A more spontaneous future for sufferers of erectile dysfunction has been heralded by the successful completion of a Phase I clinical trial of a new gene therapy which could provide six months' effect with a single dose.

Flow reactor heater for high-speed flow chemistry

By  Dr Matt Wilkinson

New flow reactor heater allows high-speed, multi-step reactions in front of your eyes allowing users to monitor progress and intervene in case problems to avoid time and reagent waste.

Nastech delays osteoporosis nasal spray development

By  Emilie Reymond

Nastech missed out on a $15m (€11m) milestone payment after having to delay the development of its new nasal spray for the treatment of osteoporosis because of the need of an additional clinical trial.

Outsource according to core competencies

By  Kirsty Barnes

Before deciding what part of a clinical trial to outsource, one of the most important things a sponsor should do is define its core competencies and then outsource accordingly.